![Alison Long](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Long
Direktor/Vorstandsmitglied bei
TAYSHA GENE THERAPIES, INC.
Vermögen: 746 535 $ am 31.05.2026
Profil
Dr. Alison Long is an Independent Director at Taysha Gene Therapies, Inc. and a Chief Medical Officer at Flightpath Biosciences, Inc. She is on the Board of Directors at Taysha Gene Therapies, Inc. Dr. Long was previously employed as a Chief Medical Officer by Anokion SA, a Chief Medical Officer by Kaleido Biosciences, Inc., a Chief Medical Officer by Freeline Therapeutics Holdings Ltd., and a Head-Clinical R&D by Spark Therapeutics, Inc. She received her undergraduate degree from the University of the Witwatersrand and a doctorate degree from George Mason University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 127’178 ( 0.05% ) | 746 535 $ | 31.05.2026 |
Aktive Positionen von Alison Long
| Unternehmen | Position | Beginn |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Direktor/Vorstandsmitglied | 01.11.2023 |
Flightpath Biosciences, Inc.
 Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
Ehemalige bekannte Positionen von Alison Long
| Unternehmen | Position | Ende |
|---|---|---|
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| KALEIDO BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 |
| SPARK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2020 |
Ausbildung von Alison Long
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
Wählen Sie MarketScreener 
